I wasn’t meaning he was the first or only one to state such, but my point was that even a newer investor can see such benefit by treating early stages of cancer.

I don’t blame anyone for being skeptical of leronlimab being successful in cancer as many very smart people and billions of dollars are spent to try and crack the code. My only hope is that RPs life’s work and the other research in CCR5 is proven so by leronlimab. It is a very interesting time for CytoDyn and cancer patients.